Monkeypox virus is a rare, sporadic and highly variable zoonotic virus, mainly found in rainforest countries in central and western Africa.
Since 2022, multiple countries including the United Kingdom, Portugal, and the United States have reported cases of monkeypox. The monkeypox epidemic has continued to escalate and has begun to spread in many countries around the world. Due to the high fatality rate of some monkeypox viruses and the absence of a specific treatment for the time being, this rare viral disease has raised global vigilance.
Since the beginning of this year, 537 people have died from monkeypox worldwide. On August 14th, the World Health Organization issued the highest-level warning. On August 15th, the General Administration of Customs of China also released an official announcement - Announcement No. 107 of 2024 on Preventing the Introduction of monkeypox into China。
It is understood that many domestic listed companies have completed the pre-research and clinical work of monkeypox virus detection kits. With Da 'an Gene obtaining the first domestic certificate for monkeypox virus nucleic acid testing, several other enterprises have followed suit in the sequence of obtaining the certificate, and over a hundred enterprises have overseas product qualifications.
Baorui Biotechnology is dedicated to the research and development, production and sales of nucleic acid testing raw materials. We can fully cooperate with various enterprises in the development of monkeypox virus nucleic acid testing kits and provide the following recommended raw materials
01 qPCRRaw material premix
02 qPCRRaw material enzyme
03 Anti-inhibitory additives
